Extramammary Paget's disease screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 3: Line 3:
{{CMG}}{{AE}}{{Simrat}}
{{CMG}}{{AE}}{{Simrat}}
==Overview==
==Overview==
According to the United States Preventive Services Task Force, screening for extramammary Paget's disease is not recommended among the general population.
According to the United States Preventive Services Task Force, [[screening]] for extramammary Paget's disease is not recommended among the general [[population]].


==Screening==
==Screening==
*Routine screening for extramammary Paget's disease in general population is not recommended.<ref name="screening">http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=extramammary+pagets+disease Accessed on January 26, 2016.</ref>
*Routine [[Screening (medicine)|screening]] for extramammary Paget's disease in general [[population]] is not recommended.<ref name="screening">http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=extramammary+pagets+disease Accessed on January 26, 2016.</ref>
*However, approximately 10% of patients with Paget's disease of the vulva have an underlying second malignancy. These include [[colorectal cancer]], cervical cancer, [[breast cancer]], as well as carcinoma of the transitional epithelium from the renal pelvis to urethra. Routine screening with [[colonoscopy]], Pap test, and mammogram may therefore be recommended in these patients.<ref name="OnaiwuRamirez2014">{{cite journal|last1=Onaiwu|first1=Cherry O.|last2=Ramirez|first2=Pedro T.|last3=Kamat|first3=Ashish|last4=Pagliaro|first4=Lance C.|last5=Euscher|first5=Elizabeth E.|last6=Schmeler|first6=Kathleen M.|title=Invasive extramammary Paget's disease of the bladder diagnosed 18years after noninvasive extramammary Paget's disease of the vulva|journal=Gynecologic Oncology Case Reports|volume=8|year=2014|pages=27–29|issn=2211338X|doi=10.1016/j.gynor.2014.03.004}}</ref>
*However, approximately 10% of patients with Paget's disease of the [[vulva]] have an underlying second [[Cancer|malignancy]]. These include [[colorectal cancer]], [[cervical cancer]], [[breast cancer]], as well as [[carcinoma]] of the [[transitional epithelium]] from the [[renal pelvis]] to [[urethra]]. Routine [[Screening (medicine)|screening]] with [[colonoscopy]], [[Pap test]], and [[mammogram]] may therefore be recommended in these [[Patient|patients]].<ref name="OnaiwuRamirez2014">{{cite journal|last1=Onaiwu|first1=Cherry O.|last2=Ramirez|first2=Pedro T.|last3=Kamat|first3=Ashish|last4=Pagliaro|first4=Lance C.|last5=Euscher|first5=Elizabeth E.|last6=Schmeler|first6=Kathleen M.|title=Invasive extramammary Paget's disease of the bladder diagnosed 18years after noninvasive extramammary Paget's disease of the vulva|journal=Gynecologic Oncology Case Reports|volume=8|year=2014|pages=27–29|issn=2211338X|doi=10.1016/j.gynor.2014.03.004}}</ref>


==References==
==References==

Latest revision as of 13:09, 10 April 2019

Extramammary Paget's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extramammary Paget's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Extramammary Paget's disease screening On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Extramammary Paget's disease screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Extramammary Paget's disease screening

CDC on Extramammary Paget's disease screening

Extramammary Paget's disease screening in the news

Blogs on Extramammary Paget's disease screening

Directions to Hospitals Treating Extramammary Paget's disease

Risk calculators and risk factors for Extramammary Paget's disease screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

According to the United States Preventive Services Task Force, screening for extramammary Paget's disease is not recommended among the general population.

Screening

References

  1. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=extramammary+pagets+disease Accessed on January 26, 2016.
  2. Onaiwu, Cherry O.; Ramirez, Pedro T.; Kamat, Ashish; Pagliaro, Lance C.; Euscher, Elizabeth E.; Schmeler, Kathleen M. (2014). "Invasive extramammary Paget's disease of the bladder diagnosed 18years after noninvasive extramammary Paget's disease of the vulva". Gynecologic Oncology Case Reports. 8: 27–29. doi:10.1016/j.gynor.2014.03.004. ISSN 2211-338X.


Template:WikiDoc Sources